Treffer: Standalone self-compartmentalizing microfluidic chip for digital single-cell antimicrobial susceptibility testing.

The growing threat of antibiotic-resistant bacteria calls for antimicrobial susceptibility testing (AST) methods that are both rapid and accessible. In this study, we demonstrate a novel approach to digital cell-based AST that leverages a passive microfluidic picochamber array to quantify bacterial growth and determine drug susceptibility at single-cell resolution. By combining stochastic confinement of individual E. coli cells with resazurin-based fluorescence detection, we establish a streamlined workflow for rapid phenotypic AST without the need for specialized equipment. The device uses capillary burst valves to autonomously guide fluid into 12,800 picoliter-sized chambers, enabling sample loading and partitioning using only a pipette and syringe. This method enables quantification of viable bacterial concentrations and determination of gentamicin minimum inhibitory concentration (MIC) breakpoints within 4 h. To evaluate its clinical potential, we tested ten clinical isolates and achieved 100 % categorical agreement with standard laboratory AST results. This work highlights a user-friendly and scalable strategy for digital AST, paving the way for broader applications in clinical diagnostics and resource-limited settings.
(Copyright © 2025 Elsevier B.V. All rights reserved.)

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.